1st International Harmony SHR® Robotic Rehabilitation System Installed at Prestigious Chinese University of Hong Kong Medical Centre

Harmonic Bionics announced today that the first Harmony SHR® exoskeleton in Hong Kong has been delivered and installed at the Chinese University of Hong Kong (CUHK) Medical Centre to be utilized in the hospital’s rehabilitation program. This marks the very first international placement for Harmonic Bionics and the first in the Hong Kong region with the company’s distributor, Healthlink Holdings.

Harmony SHR is a bilateral upper extremity exoskeleton with a biomechanically matched shoulder designed to allow a larger and more natural arm range of motion for patients recovering from neurological or musculoskeletal impairments. Harmonic Bionics announced the commercial launch of Harmony SHR last April followed by the first US installation at a top neurological hospital in Phoenix.

A high-profile dancer that suffered a spinal cord injury in an accident on stage two years ago was one of the first to use the Harmony SHR exoskeleton at CUHK Medical Centre, under the care of Professor Herman Lau, Director of Allied Health Services, and former Hospital Chief Executive of Shatin Hospital.

“The Harmony SHR exoskeleton is a highly unique robotic device that has been specifically designed for bilateral upper body rehabilitation purposes. The CUHK Medical Centre is proud to announce that it has recently acquired the first Harmony device in Hong Kong,” said Professor Herman Lau. “Patients who have been using the Harmony system have shown remarkable motivation and enthusiasm, which has resulted in some promising outcomes in a relatively short period of time.”

Harmonic Bionics CEO Mark Hunter

“This is a major milestone for our company as we work to expand our footprint and bring Harmony SHR to more providers and patients. There is tremendous opportunity for growth in Asia and this installation at CUHK Medical Centre is a great starting point to our intended success in the market.”

Hot this week

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”

Avery Dennison Medical Introduces Ipdated SilFoam Lite: Sustainability, MDR Certification & Performance Improvements

The newly enhanced SilFoam Lite delivers superior efficiency and reliability, bringing improved fluid handling capabilities and improved tack. These improvements make the product ideal for customers seeking quality, high-performance solutions in wound care notes Avery Dennison Medical.

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."